Aehr Test Systems (AEHR) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AEHR shares.
View AEHR analyst ratings or view top-rated stocks.

1 brokerages have issued 1 year price targets for Aehr Test Systems' stock. Their AEHR share price forecasts range from $45.00 to $45.00. On average, they predict the company's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 8.8% from the stock's current price.
View analysts price targets for AEHR or view top-rated stocks among Wall Street analysts.

Aehr Test Systems' stock was trading at $20.10 at the beginning of the year. Since then, AEHR shares have increased by 105.8% and is now trading at $41.36.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 18th 2023.
View our AEHR earnings forecast.

Aehr Test Systems (NASDAQ:AEHR) issued its earnings results on Thursday, March, 30th. The semiconductor company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by $0.02. The semiconductor company had revenue of $17.21 million for the quarter, compared to analysts' expectations of $17 million. Aehr Test Systems had a trailing twelve-month return on equity of 24.98% and a net margin of 22.61%. During the same period in the prior year, the business earned $0.11 earnings per share.

ETFs with the largest weight of Aehr Test Systems (NASDAQ:AEHR) stock in their portfolio include Changebridge Select Equity ETF (CBSE), Changebridge Long/Short Equity ETF (CBLS), SPDR FactSet Innovative Technology ETF (XITK), Invesco DWA SmallCap Momentum ETF (DWAS), Invesco Nasdaq Future Gen 200 ETF (QQQS) and iShares Micro-Cap ETF (IWC),

Aehr Test Systems issued an update on its FY 2023 earnings guidance on Friday, April, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $60.00 million-$70.00 million, compared to the consensus revenue estimate of $65.17 million.

1 employees have rated Aehr Test Systems Chief Executive Officer Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among the company's employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Aehr Test Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include Hood River Capital Management LLC (5.45%), Ameriprise Financial Inc. (4.85%), FMR LLC (3.34%), BlackRock Inc. (1.83%), Dimensional Fund Advisors LP (1.16%) and Renaissance Technologies LLC (1.04%). Insiders that own company stock include Alistair N Sporck, David Fucci, David S Hendrickson, Donald P Richmond II, Gayn Erickson, Geoffrey Gates Scott, Howard T Slayen, Kenneth B Spink, Kenneth B Spink, Laura Oliphant, Mario M Rosati, Michael A Brannan, Rhea J Posedel and Vernon Rogers.
View institutional ownership trends.

Shares of AEHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEHR stock can currently be purchased for approximately $41.36.

Aehr Test Systems (NASDAQ:AEHR) has a market capitalization of $1.17 billion and generates $50.83 million in revenue each year. The semiconductor company earns $9.45 million in net income (profit) each year or $0.49 on an earnings per share basis.

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The official website for the company is www.aehr.com. The semiconductor company can be reached via phone at (510) 623-9400, via email at aehr@mkr-group.com, or via fax at 510-623-9450.